You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HDT/ASCT

Showing 1 - 25 of 265
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in New York (Tremelimumab, Durvalumab, Prevnar-13)

Terminated
Has Results
  • Multiple Myeloma
  • New York, New York
  • +1 more
Oct 3, 2022

Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial (procedure, drug, biological, radiation, other)

Not yet recruiting
  • Recurrent Classic Hodgkin Lymphoma
  • Refractory Classic Hodgkin Lymphoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +13 more
  • (no location specified)
Feb 2, 2023

Large B-cell Lymphoma Trial in Tianjin (CNCT19, Gemcitabine Injection, busulfan)

Recruiting
  • Large B-cell Lymphoma
  • CNCT19
  • +3 more
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jan 24, 2022

Diffuse Large B-cell Lymphoma (DLBCL), Relapsed Diffuse Large B-cell Lymphoma (DLBCL), Refractory Diffuse Large B-cell Lymphoma

Recruiting
  • Diffuse Large B-cell Lymphoma (DLBCL)
  • +2 more
  • leukapheresis
  • +3 more
  • Omaha, Nebraska
  • +13 more
Jan 21, 2022

Autologous Stem Cell Transplant Trial in Edmonton (Airvo)

Not yet recruiting
  • Autologous Stem Cell Transplant
  • Airvo
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Apr 28, 2022

Multiple Myeloma Trial in Germany (Teclistamab (Tec), Daratumumab, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Teclistamab (Tec)
  • +4 more
  • Berlin, Germany
  • +8 more
Jan 19, 2023

Lymphoma, T-Cell, Peripheral Trial in Czechia (Adcetris 50 MG Injection, Endoxan, Doxorubicin)

Not yet recruiting
  • Lymphoma, T-Cell, Peripheral
  • Adcetris 50 MG Injection
  • +4 more
  • Brno, Czechia
  • +6 more
Aug 26, 2021

Peripheral T Cell Lymphoma Trial in France (Chemotherapy + follow up, Chemotherapy + ASCT + follow up)

Recruiting
  • Peripheral T Cell Lymphoma
  • Chemotherapy + follow up
  • Chemotherapy + ASCT + follow up
  • Amiens, France
  • +47 more
Aug 2, 2022

Lymphoma Trial in Hangzhou (Autologous hematopoietic stem cell transplantation combined with CD19 CAR-T cells)

Recruiting
  • Lymphoma
  • Autologous hematopoietic stem cell transplantation combined with CD19 CAR-T cells
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Feb 13, 2022

Lymphoma Trial in United States (carmustine, cytarabine, etoposide)

Active, not recruiting
  • Lymphoma
  • Anchorage, Alaska
  • +125 more
Aug 16, 2021

Mantle Cell Lymphoma Trial in United States (R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.)

Active, not recruiting
  • Mantle Cell Lymphoma
  • R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.
  • Basking Ridge, New Jersey
  • +4 more
Dec 1, 2022

Diffuse Large B-cell Lymphoma Trial in Worldwide (Epcoritamab, Investigator's Choice Chemotherapy)

Recruiting
  • Diffuse Large B-cell Lymphoma
  • Epcoritamab
  • Investigator's Choice Chemotherapy
  • Irvine, California
  • +254 more
Jan 9, 2023

Multiple Myeloma Trial in Creteil (Whole Body Dynamic Contrast Enhanced MRI (WB-DCE-MRI))

Completed
  • Multiple Myeloma
  • Whole Body Dynamic Contrast Enhanced MRI (WB-DCE-MRI)
  • Creteil, France
    Henri Mondor Hospital
Nov 19, 2020

Smoldering Multiple Myeloma Trial in Spain (carfilzomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Smoldering Multiple Myeloma
  • Barcelona, Spain
  • +15 more
Feb 15, 2021

Classical Hodgkin Lymphoma Trial in Guangzhou (Zimberelimab 240mg)

Recruiting
  • Classical Hodgkin Lymphoma
  • Zimberelimab 240mg
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-Sen University Cancer Ce
Jun 15, 2023

Multiple Myeloma Trial (Linvoseltamab)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Apr 12, 2023

Hodgkin Lymphoma, Non-hodgkin Lymphoma Trial in United States (AB-205)

Completed
  • Hodgkin Lymphoma
  • Non-hodgkin Lymphoma
  • AB-205
  • Duarte, California
  • +8 more
Mar 1, 2022

Multiple Myeloma Trial in Ann Arbor, Milwaukee (Autologous Stem Cell Transplant, Melphalan, Lenalidomide)

Completed
Has Results
  • Multiple Myeloma
  • Autologous Stem Cell Transplant
  • +3 more
  • Ann Arbor, Michigan
  • +1 more
Jul 2, 2018

Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell Trial in China (Chidamide, Cladribine, Gemcitabine)

Recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, T-Cell
  • Deyang, Deyang, China
  • +10 more
Jul 21, 2022

Multiple Myeloma Trial in Germany (Lenalidomide, Bortezomib, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Aachen, Germany
  • +72 more
Jan 12, 2022

Newly Diagnosed Multiple Myeloma Trial in Austria, Germany (Elotuzumab, Carfilzomib, Lenalidomide)

Active, not recruiting
  • Newly Diagnosed Multiple Myeloma
  • Krems, Lower Austria, Austria
  • +55 more
Jan 4, 2022

T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)

Terminated
Has Results
  • T-cell Non-Hodgkin Lymphoma
  • Boston, Massachusetts
  • +1 more
Jan 26, 2023

Allo-HSCT as First-line Consolidation in High-risk PTCL

Recruiting
  • T Cell Lymphoma
    • Beijing, China
      Peking University People's Hospital
    Jul 31, 2022

    SARS-CoV-2 Trial in Salvador (Cohort 1 VACCINE RNA MCTI CIMATEC HDT (HDT-301) vaccine, Cohort 2 RNA VACCINE MCTI CIMATEC

    Recruiting
    • SARS-CoV-2
    • Cohort 1 VACCINE RNA MCTI CIMATEC HDT (HDT-301) vaccine
    • +3 more
    • Salvador, Bahia, Brazil
      Hospital da Bahia
    Mar 23, 2022

    Multiple Myeloma Trial in Suzhou (Tocilizumab)

    Recruiting
    • Multiple Myeloma
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    May 3, 2023